Literature DB >> 19505468

Enzymes of the antioxidant network as novel determiners of Trypanosoma cruzi virulence.

L Piacenza1, M P Zago, G Peluffo, M N Alvarez, M A Basombrio, R Radi.   

Abstract

Virulence of Trypanosoma cruzi depends on a variety of genetic and biochemical factors. It has been proposed that components of the parasites' antioxidant system may play a key part in this process by pre-adapting the pathogen to the oxidative environment encountered during host cell invasion. Using several isolates (10 strains) belonging to the two major phylogenetic lineages (T. cruzi-I and T. cruzi-II), we investigated whether there was an association between virulence (ranging from highly aggressive to attenuated isolates at the parasitemia and histopathological level) and the antioxidant enzyme content. Antibodies raised against trypanothione synthetase (TcTS), ascorbate peroxidase (TcAPX), mitochondrial and cytosolic tryparedoxin peroxidases (TcMPX and TcCPX) and trypanothione reductase (TcTR) were used to evaluate the antioxidant enzyme levels in epimastigote and metacyclic trypomastigote forms in the T. cruzi strains. Levels of TcCPX, TcMPX and TcTS were shown to increase during differentiation from the non-infective epimastigote to the infective metacyclic trypomastigote stage in all parasite strains examined. Peroxiredoxins were found to be present at higher levels in the metacyclic infective forms of the virulent isolates compared with the attenuated strains. Additionally, an increased resistance of epimastigotes from virulent T. cruzi populations to hydrogen peroxide and peroxynitrite challenge was observed. In mouse infection models, a direct correlation was found between protein levels of TcCPX, TcMPX and TcTS, and the parasitemia elicited by the different isolates studied (Pearson's coefficient: 0.617, 0.771, 0.499; respectively, P<0.01). No correlation with parasitemia was found for TcAPX and TcTR proteins in any of the strains analyzed. Our data support that enzymes of the parasite antioxidant armamentarium at the onset of infection represent new virulence factors involved in the establishment of disease.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505468      PMCID: PMC3909716          DOI: 10.1016/j.ijpara.2009.05.010

Source DB:  PubMed          Journal:  Int J Parasitol        ISSN: 0020-7519            Impact factor:   3.981


  45 in total

1.  Staining and quantification of proteins transferred to polyvinylidene fluoride membranes.

Authors:  M K Moore; S M Viselli
Journal:  Anal Biochem       Date:  2000-03-15       Impact factor: 3.365

2.  Trypanosomes lacking trypanothione reductase are avirulent and show increased sensitivity to oxidative stress.

Authors:  S Krieger; W Schwarz; M R Ariyanayagam; A H Fairlamb; R L Krauth-Siegel; C Clayton
Journal:  Mol Microbiol       Date:  2000-02       Impact factor: 3.501

3.  Purification and biochemical characterization of four iron superoxide dismutases in Trypanosoma cruzi.

Authors:  Héctor Mateo; Clotilde Marín; Gregorio Pérez-Cordón; Manuel Sánchez-Moreno
Journal:  Mem Inst Oswaldo Cruz       Date:  2008-05       Impact factor: 2.743

Review 4.  Glutathione and trypanothione in parasitic hydroperoxide metabolism.

Authors:  L Flohé; H J Hecht; P Steinert
Journal:  Free Radic Biol Med       Date:  1999-11       Impact factor: 7.376

5.  Mitochondrial superoxide radicals mediate programmed cell death in Trypanosoma cruzi: cytoprotective action of mitochondrial iron superoxide dismutase overexpression.

Authors:  Lucía Piacenza; Florencia Irigoín; María Noel Alvarez; Gonzalo Peluffo; Martin C Taylor; John M Kelly; Shane R Wilkinson; Rafael Radi
Journal:  Biochem J       Date:  2007-04-15       Impact factor: 3.857

Review 6.  Insights into the redox biology of Trypanosoma cruzi: Trypanothione metabolism and oxidant detoxification.

Authors:  Florencia Irigoín; Lucía Cibils; Marcelo A Comini; Shane R Wilkinson; Leopold Flohé; Rafael Radi
Journal:  Free Radic Biol Med       Date:  2008-06-12       Impact factor: 7.376

7.  Peroxiredoxins play a major role in protecting Trypanosoma cruzi against macrophage- and endogenously-derived peroxynitrite.

Authors:  Lucía Piacenza; Gonzalo Peluffo; María Noel Alvarez; John M Kelly; Shane R Wilkinson; Rafael Radi
Journal:  Biochem J       Date:  2008-03-01       Impact factor: 3.857

8.  Peroxiredoxins from Trypanosoma cruzi: virulence factors and drug targets for treatment of Chagas disease?

Authors:  María Dolores Piñeyro; Adriana Parodi-Talice; Talia Arcari; Carlos Robello
Journal:  Gene       Date:  2007-10-22       Impact factor: 3.688

9.  Proteomic analysis of metacyclic trypomastigotes undergoing Trypanosoma cruzi metacyclogenesis.

Authors:  A Parodi-Talice; V Monteiro-Goes; N Arrambide; A R Avila; R Duran; A Correa; B Dallagiovanna; A Cayota; M Krieger; S Goldenberg; C Robello
Journal:  J Mass Spectrom       Date:  2007-11       Impact factor: 1.982

Review 10.  Redox control in trypanosomatids, parasitic protozoa with trypanothione-based thiol metabolism.

Authors:  R Luise Krauth-Siegel; Marcelo A Comini
Journal:  Biochim Biophys Acta       Date:  2008-03-18
View more
  44 in total

Review 1.  Peroxiredoxins in parasites.

Authors:  Michael C Gretes; Leslie B Poole; P Andrew Karplus
Journal:  Antioxid Redox Signal       Date:  2012-01-25       Impact factor: 8.401

Review 2.  Mechanisms of Trypanosoma cruzi persistence in Chagas disease.

Authors:  Fnu Nagajyothi; Fabiana S Machado; Barbara A Burleigh; Linda A Jelicks; Philipp E Scherer; Shankar Mukherjee; Michael P Lisanti; Louis M Weiss; Nisha J Garg; Herbert B Tanowitz
Journal:  Cell Microbiol       Date:  2012-02-24       Impact factor: 3.715

3.  Intraphagosomal peroxynitrite as a macrophage-derived cytotoxin against internalized Trypanosoma cruzi: consequences for oxidative killing and role of microbial peroxiredoxins in infectivity.

Authors:  María Noel Alvarez; Gonzalo Peluffo; Lucía Piacenza; Rafael Radi
Journal:  J Biol Chem       Date:  2010-11-23       Impact factor: 5.157

4.  Role of Trypanosoma cruzi peroxiredoxins in mitochondrial bioenergetics.

Authors:  Eduardo de Figueiredo Peloso; Simone Cespedes Vitor; Luis Henrique Gonzaga Ribeiro; María Dolores Piñeyro; Carlos Robello; Fernanda Ramos Gadelha
Journal:  J Bioenerg Biomembr       Date:  2011-07-06       Impact factor: 2.945

5.  Synthesis and evaluation of the antileishmanial activity of silver compounds containing imidazolidine-2-thione.

Authors:  Patrícia Ferreira Espuri; Larissa Luiza Dos Reis; Eduardo de Figueiredo Peloso; Vanessa Silva Gontijo; Fábio Antônio Colombo; Juliana Barbosa Nunes; Carine Ervolino de Oliveira; Eduardo T De Almeida; Débora E S Silva; Jessica Bortoletto; Daniel Fonseca Segura; Adelino V G Netto; Marcos José Marques
Journal:  J Biol Inorg Chem       Date:  2019-04-04       Impact factor: 3.358

Review 6.  Redox metabolism in mitochondria of trypanosomatids.

Authors:  Ana M Tomás; Helena Castro
Journal:  Antioxid Redox Signal       Date:  2012-11-15       Impact factor: 8.401

Review 7.  Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens.

Authors:  Carolina Prolo; María Noel Alvarez; Rafael Radi
Journal:  Biofactors       Date:  2013-11-26       Impact factor: 6.113

8.  Macrophages Promote Oxidative Metabolism To Drive Nitric Oxide Generation in Response to Trypanosoma cruzi.

Authors:  Sue-Jie Koo; Imran H Chowdhury; Bartosz Szczesny; Xianxiu Wan; Nisha J Garg
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

Review 9.  Pathology and Pathogenesis of Chagas Heart Disease.

Authors:  Kevin M Bonney; Daniel J Luthringer; Stacey A Kim; Nisha J Garg; David M Engman
Journal:  Annu Rev Pathol       Date:  2018-10-24       Impact factor: 23.472

10.  Trypanothione synthetase confers growth, survival advantage and resistance to anti-protozoal drugs in Trypanosoma cruzi.

Authors:  Andrea C Mesías; Natalia Sasoni; Diego G Arias; Cecilia Pérez Brandán; Oliver C F Orban; Conrad Kunick; Carlos Robello; Marcelo A Comini; Nisha J Garg; M Paola Zago
Journal:  Free Radic Biol Med       Date:  2018-10-23       Impact factor: 7.376

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.